Cyclacel Pharmaceuti (CYCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYCC | DRMA | ATNF | ||
| Company | Cyclacel Pharmaceuti | Dermata Therapeutics Inc | 180 Life Sciences Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.3390 | 1.0700 | 1.9800 | ||
| High | 0.3500 | 1.1473 | 2.0200 | ||
| Low | 0.3174 | 1.0604 | 1.8600 | ||
| Last | 0.3174 | 1.0800 | 1.8600 | ||
| Change | -0.0136 | +0.0300 | -0.0800 | ||
| % Change | -4.11% | +2.86% | -4.12% | ||
| Volume | 392,200 | 159,000 | 54,500 | ||
| 20-Day Average Volume | 446,145 | 572,820 | 129,780 | ||
| Previous Close | 0.3310 | 1.0500 | 1.9400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3722 | 1.1763 | 2.0855 | ||
| 20-Day Raw Stochastic | 0.00% | 17.78% | 15.67% | ||
| 20-Day Relative Strength | 35.51% | 43.04% | 41.44% | ||
| Weighted Alpha | -92.51 | -89.41 | -87.86 | ||
| Today's Opinion | 100% Sell | 100% Sell | 40% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.10% since 12/13/24 | -0.92% since 12/13/24 | -3.63% since 12/13/24 | ||
| Low | 0.3174 on 12/20/24 | 1.0000 on 12/19/24 | 1.6900 on 12/17/24 | ||
| High | 0.3738 on 12/18/24 | 1.1473 on 12/20/24 | 2.0200 on 12/20/24 | ||
| 1-Month | |||||
| %Chg | -14.52% since 11/20/24 | -6.90% since 11/20/24 | -20.51% since 11/20/24 | ||
| Low | 0.3174 on 12/20/24 | 1.0000 on 12/19/24 | 1.6900 on 12/17/24 | ||
| High | 0.4650 on 12/03/24 | 1.4500 on 12/09/24 | 2.7750 on 12/02/24 | ||
| 3-Month | |||||
| %Chg | -67.61% since 09/20/24 | -39.33% since 09/20/24 | -5.58% since 09/20/24 | ||
| Low | 0.3174 on 12/20/24 | 1.0000 on 12/19/24 | 1.1600 on 10/08/24 | ||
| High | 2.4900 on 10/22/24 | 1.8200 on 09/23/24 | 17.7500 on 10/16/24 | ||
| 6-Month | |||||
| %Chg | -80.76% since 06/20/24 | -54.81% since 06/20/24 | +14.11% since 06/20/24 | ||
| Low | 0.3174 on 12/20/24 | 1.0000 on 12/19/24 | 1.1600 on 10/08/24 | ||
| High | 2.4900 on 10/22/24 | 5.0000 on 07/24/24 | 17.7500 on 10/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,996 | 2,204 | 1,910 | ||
| Shares Outstanding, K | 6,287 | 2,041 | 1,027 | ||
| Annual Sales | 420,000 | 0 | 0 | ||
| Annual Net Income | -22,560,000 | -7,790,000 | -19,940,000 | ||
| Last Quarter Sales | 10,000 | 0 | 0 | ||
| Last Quarter Net Income | -1,960,000 | -3,170,000 | -840,000 | ||
| 60-Month Beta | 0.38 | 0.79 | 0.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/12/24 | -2.04 on 11/13/24 | -0.85 on 11/14/24 | ||
| Latest Earnings Date | 11/11/24 | 11/14/24 | 11/14/24 | ||
| Most Recent Dividend | 0.150 on 07/13/16 | N/A | N/A | ||
| Next Ex-Dividends Date | 07/13/16 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||